Eyam Vaccines and Immunotherapeutics: Funding & Investors (Sep 2026)
Eyam Vaccines and Immunotherapeutics specializes in developing and researching vaccines to protect against contagious illnesses.
Eyam Vaccines and Immunotherapeutics has raised $330k across 2 funding rounds on record, the most recent an undisclosed round of $330k announced in Jan 2026.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Eyam Vaccines and Immunotherapeutics Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Eyam Vaccines and Immunotherapeutics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Eyam Vaccines and Immunotherapeutics announced an undisclosed round in Oct 2025; the amount was not disclosed.
3 months later, an undisclosed round of $330k was announced in Jan 2026.
Eyam Vaccines and Immunotherapeutics Founders and Leadership Team
Contact details for the Eyam Vaccines and Immunotherapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Eyam Vaccines and Immunotherapeutics Funding Compared to Other Health Care Startups
Eyam Vaccines and Immunotherapeutics' latest round of $330k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Eyam Vaccines and Immunotherapeutics in Health Care and Surrey
Companies Similar to Eyam Vaccines and Immunotherapeutics
Cuffway develops medical devices for automated, real-time regulation of endotracheal tube cuff pressure to…
Principal Technologies is a Canadian business that invests in healthcare technologies.
Developing Life Altering Treatments for Patients Suffering from Rare Chronic Diseases.
Optimi Health is a supplier of natural, pharmaceutical-grade psilocybin and synthetic psychedelic compounds.…
Kare specializes in the research, development, and commercialization of catalysts, precursors, and industrial…
Synakis patented a biodegradable hydrogel vitreous substitute that is injectable, non-cytotoxic in vitro and…
Canadian Coalition for Seniors' Mental Health works to promote seniors' mental health by connecting people,…
Jack.org is a charitable group that instructs and strengthens young pioneers to change the field of mental…
Aplantex produces plant-based active compounds for application in the pharma, cosmetics, and agri-food…
Perimeter Medical Imaging is a medical technology company driven to transform cancer surgery with ultra-high…
Leveljump Healthcare offers radiology solutions for hospitals, emergency rooms, and private clinics. They…
Psyched Wellness is a Canadian-based company improving the health and wellness of millions with high-quality…
Eyam Vaccines and Immunotherapeutics Funding FAQs
What does Eyam Vaccines and Immunotherapeutics do?
Eyam Vaccines and Immunotherapeutics specializes in developing and researching vaccines to protect against contagious illnesses.
How much funding has Eyam Vaccines and Immunotherapeutics raised?
Eyam Vaccines and Immunotherapeutics has raised $330k across 2 rounds on record. The most recent is an undisclosed round of $330k announced in Jan 2026.
When did Eyam Vaccines and Immunotherapeutics last raise funding?
Eyam Vaccines and Immunotherapeutics' most recent funding round on record is an undisclosed round of $330k, announced in Jan 2026.
Who founded Eyam Vaccines and Immunotherapeutics?
FundedIQ lists Wilfred Jefferies (Founder) at Eyam Vaccines and Immunotherapeutics.
Where is Eyam Vaccines and Immunotherapeutics headquartered?
Eyam Vaccines and Immunotherapeutics is based in Surrey, British Columbia, Canada.
How many employees does Eyam Vaccines and Immunotherapeutics have?
Eyam Vaccines and Immunotherapeutics is in the 11-50 employee band.
How does Eyam Vaccines and Immunotherapeutics' funding compare to other Health Care startups?
Eyam Vaccines and Immunotherapeutics' latest round of $330k is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Eyam Vaccines and Immunotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Eyam Vaccines and Immunotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.